Cardiac Magnetic Resonance in the Evaluation of COVID-19
Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populatio...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2022-03-01
|
| Series: | Cardiac Failure Review |
| Online Access: | https://www.cfrjournal.com/articleindex/cfr.2021.20 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850104217194201088 |
|---|---|
| author | Daniel E Clark Sachin K Aggarwal Neil J Phillips Jonathan H Soslow Jeffrey M Dendy Sean G Hughes |
| author_facet | Daniel E Clark Sachin K Aggarwal Neil J Phillips Jonathan H Soslow Jeffrey M Dendy Sean G Hughes |
| author_sort | Daniel E Clark |
| collection | DOAJ |
| description | Cardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings. |
| format | Article |
| id | doaj-art-4e8bcf08ffb04b299703ffd3f436e39c |
| institution | DOAJ |
| issn | 2057-7540 2057-7559 |
| language | English |
| publishDate | 2022-03-01 |
| publisher | Radcliffe Medical Media |
| record_format | Article |
| series | Cardiac Failure Review |
| spelling | doaj-art-4e8bcf08ffb04b299703ffd3f436e39c2025-08-20T02:39:22ZengRadcliffe Medical MediaCardiac Failure Review2057-75402057-75592022-03-01810.15420/cfr.2021.20Cardiac Magnetic Resonance in the Evaluation of COVID-19Daniel E Clark0Sachin K Aggarwal1Neil J Phillips2Jonathan H Soslow3Jeffrey M Dendy4Sean G Hughes5Division of Cardiovascular Medicine, Department of Internal Medicine, Vanderbilt University Medical Centre, Nashville, TN, USVanderbilt School of Medicine, Vanderbilt University, Nashville, TN, USDepartment of Internal Medicine, Vanderbilt University Medical Centre, Nashville, TN, USThomas P Graham Division of Paediatric Cardiology, Department of Paediatrics, Monroe Carell Jr Children’s Hospital at Vanderbilt, Nashville, TN, USDivision of Cardiovascular Medicine, Department of Internal Medicine, Vanderbilt University Medical Centre, Nashville, TN, USDivision of Cardiovascular Medicine, Department of Internal Medicine, Vanderbilt University Medical Centre, Nashville, TN, USCardiovascular involvement following COVID-19 is heterogeneous, prevalent and is often missed by echocardiography and serum biomarkers (such as troponin I and brain natriuretic peptide). Cardiac magnetic resonance (CMR) is the gold standard non-invasive imaging modality to phenotype unique populations after COVID-19, such as competitive athletes with a heightened risk of sudden cardiac death, patients with multisystem inflammatory syndrome, and people suspected of having COVID-19 vaccine-induced myocarditis. This review summarises the key attributes of CMR, reviews the literature that has emerged for using CMR for people who may have COVID-19-related complications after COVID-19, and offers expert opinion regarding future avenues of investigation and the importance of reporting findings.https://www.cfrjournal.com/articleindex/cfr.2021.20 |
| spellingShingle | Daniel E Clark Sachin K Aggarwal Neil J Phillips Jonathan H Soslow Jeffrey M Dendy Sean G Hughes Cardiac Magnetic Resonance in the Evaluation of COVID-19 Cardiac Failure Review |
| title | Cardiac Magnetic Resonance in the Evaluation of COVID-19 |
| title_full | Cardiac Magnetic Resonance in the Evaluation of COVID-19 |
| title_fullStr | Cardiac Magnetic Resonance in the Evaluation of COVID-19 |
| title_full_unstemmed | Cardiac Magnetic Resonance in the Evaluation of COVID-19 |
| title_short | Cardiac Magnetic Resonance in the Evaluation of COVID-19 |
| title_sort | cardiac magnetic resonance in the evaluation of covid 19 |
| url | https://www.cfrjournal.com/articleindex/cfr.2021.20 |
| work_keys_str_mv | AT danieleclark cardiacmagneticresonanceintheevaluationofcovid19 AT sachinkaggarwal cardiacmagneticresonanceintheevaluationofcovid19 AT neiljphillips cardiacmagneticresonanceintheevaluationofcovid19 AT jonathanhsoslow cardiacmagneticresonanceintheevaluationofcovid19 AT jeffreymdendy cardiacmagneticresonanceintheevaluationofcovid19 AT seanghughes cardiacmagneticresonanceintheevaluationofcovid19 |